Geron Stock (NASDAQ: GERN) stock price, news, charts, stock research, profile.
Open | $3.880 |
Close | - |
Volume / Avg. | 15.546M / 12.749M |
Day Range | 3.770 - 4.260 |
52 Wk Range | 1.640 - 4.050 |
Market Cap | $2.494B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 73 |
Short Interest | 7.97% |
Days to Cover | 3.65 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Geron (NASDAQ: GERN) through any online brokerage.
Other companies in Geron’s space includes: Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), PTC Therapeutics (NASDAQ:PTCT), TG Therapeutics (NASDAQ:TGTX) and Arrowhead Pharma (NASDAQ:ARWR).
The latest price target for Geron (NASDAQ: GERN) was reported by TD Cowen on Monday, April 29, 2024. The analyst firm set a price target for 10.00 expecting GERN to rise to within 12 months (a possible 136.13% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Geron (NASDAQ: GERN) is $4.235 last updated Today at April 29, 2024 at 1:26 PM EDT.
There are no upcoming dividends for Geron.
Geron’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Geron.
Geron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.